Embecta Corp (EMBC)
Cash ratio
| Sep 30, 2023 | Sep 30, 2022 | ||
|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 326,500 | 330,900 |
| Short-term investments | US$ in thousands | — | — |
| Total current liabilities | US$ in thousands | 353,500 | 301,000 |
| Cash ratio | 0.92 | 1.10 |
September 30, 2023 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($326,500K
+ $—K)
÷ $353,500K
= 0.92
Peer comparison
Sep 30, 2023
Company name
Symbol
Cash ratio
Embecta Corp
EMBC
0.92
3M Company
MMM
0.39
Artivion Inc
AORT
1.02
Baxter International Inc
BAX
0.49
Becton Dickinson and Company
BDX
0.21
Boston Scientific Corp
BSX
0.18
DexCom Inc
DXCM
1.75
Glaukos Corp
GKOS
3.99
Globus Medical
GMED
1.45
Haemonetics Corporation
HAE
0.60
ICU Medical Inc
ICUI
0.53